Israel China Biotechnology (ICB) Ltd (ICB) — Net Asset Momentum
Israel China Biotechnology (ICB) Ltd (ICB) recorded a net asset momentum of -75.1% as of December 2020, with net assets of ILA470.00K ILA. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Israel China Biotechnology (ICB) Ltd net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Israel China Biotechnology (ICB) Ltd Net Asset Momentum (2015–2020)
This chart tracks Israel China Biotechnology (ICB) Ltd's year-over-year net asset growth across 6 annual reporting periods from 2015 to 2020. The most recent momentum reading is -75.1%, with net assets of ILA470.00K ILA as of December 2020. For live market cap and overall valuation, see Israel China Biotechnology (ICB) Ltd stock valuation.
Annual Net Asset History for Israel China Biotechnology (ICB) Ltd (2015–2020)
The table below shows the complete annual net asset history for Israel China Biotechnology (ICB) Ltd from 2015 to 2020, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check ICB tangible net assets ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (ILA) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2020 | ILA470.00K | ILA8.34 Million | ILA7.87 Million | ▼ -75.1% |
| 2019 | ILA1.89 Million | ILA11.57 Million | ILA9.68 Million | ▼ -74.5% |
| 2018 | ILA7.41 Million | ILA9.88 Million | ILA2.46 Million | ▲ +539.4% |
| 2017 | ILA-1.69 Million | ILA1.18 Million | ILA2.87 Million | ▼ -188.5% |
| 2016 | ILA1.91 Million | ILA4.06 Million | ILA2.15 Million | ▼ -67.0% |
| 2015 | ILA5.78 Million | ILA8.18 Million | ILA2.39 Million | — |